All In Biotech

Drug Trial Radar · NCT01607476

Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)

Bridging Study of C11 PiB and F18 Flutemetamol Brain PET

Last checked: Nov 20, 2026Latest source record: Apr 18, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

89

Actual

Start

Jul 2012

Primary completion

Dec 2014

Study completion Mar 2016

Sponsor

Lead sponsor
Mayo ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 30, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
Who can join
All sexes, from 30 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The intent of this research protocol is to test the equivalency of two amyloid imaging drugs (C11 Pittsburgh Compound B and F18 Flutemetamol). The investigators hypothesize that there will be no significant difference in the distribution of the agents to areas of amyloid deposition in the brain or to other normal brain structures. Recent data have shown similarity in the distribution of the drugs in subjects with Alzheimer's disease (AD) or mild cognitive impairment (MCI). No comparison data of the two PET drugs in normal subjects has been published. It is important to understand differences in the images and biodistribution from the two drugs in normal subjects as nonspecific accumulation of the drugs in brain structures such as white matter appear to differ slightly and could affect image performance.

Conditions

  • Alzheimer's Disease

Interventions

  • C11 PiBDrug

    One time intravenous administration of 8-22 millicurie (mCi) C11 PiB

  • F18 FlutametamolDrug

    One time intravenous administration of 3-7 mCi F18 Flutametamol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Global Distribution of C11 PiB in the BrainTime frame: Approximately one hour after injection of positron emission tomography (PET) drug
  2. Global Distribution of F18 Flutemetamol in the BrainTime frame: Approximately one hour after injection of positron emission tomography (PET) drug

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic Rochester

    Rochester, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.